| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | FOXO3 SP1 HNF1A NACA ZMYND8 SRF NSD1 RUNX3 MEF2A TFDP2 HIRA MED19 PER3 HEY1 NCOA1 MYOCD NR3C2 PRAME LRIF1 CNOT2 HTT | 7.39e-07 | 753 | 161 | 21 | GO:0008134 |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 2.05e-06 | 4 | 161 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 3.25e-06 | 29 | 161 | 5 | GO:0035035 | |
| GeneOntologyMolecularFunction | chromatin binding | MKRN4P FOXO3 TICRR HNF1A VAX1 MKRN1 SRF NSD1 POU2F1 PHF8 MEF2A HIRA MSL2 PHC3 GLI3 NFKB1 NCOA1 ANKRD17 | 3.00e-05 | 739 | 161 | 18 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L NACA ZMYND8 NSD1 GON4L PHF8 HIRA MED19 NFKB1 NCOA1 MYOCD MAML2 CAMTA1 CNOT2 WWC1 | 5.17e-05 | 562 | 161 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.42e-04 | 140 | 161 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXO3 SP1 HNF1A VAX1 SRF NSD1 POU2F1 RFX7 ZNF236 RUNX3 MEF2A HIVEP3 SLC2A4RG HEY1 GLI3 NFKB1 ZFHX3 ELF4 NR3C2 ELK3 HSF2 ZNF646 | 4.27e-04 | 1244 | 161 | 22 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXO3 SP1 HNF1A VAX1 SRF NSD1 POU2F1 RFX7 ZNF236 RUNX3 MEF2A HIVEP3 SLC2A4RG HEY1 GLI3 NFKB1 ZFHX3 ELF4 NR3C2 ELK3 HSF2 ZNF646 | 5.71e-04 | 1271 | 161 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXO3 SP1 HNF1A VAX1 SRF NSD1 POU2F1 RFX7 ZNF236 RUNX3 MEF2A TFDP2 HIVEP3 SLC2A4RG HEY1 GLI3 NFKB1 NCOA1 ZFHX3 ELF4 NR3C2 ELK3 HSF2 ZNF646 | 6.52e-04 | 1459 | 161 | 24 | GO:0000977 |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.01e-03 | 55 | 161 | 4 | GO:0042974 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZNF438 FOXO3 HNF1A VAX1 ARID4B NACA ZMYND8 SRF NSD1 ZMYM2 GON4L POU2F1 MAGEE2 DEPDC1 RUNX3 MEF2A TFDP2 HIRA PHC3 PER3 HEY1 GLI3 NFKB1 ZFHX3 MYOCD ELK3 MAGEC1 PRAME CNOT2 WWC1 | 3.24e-07 | 1399 | 160 | 30 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZNF438 FOXO3 HNF1A VAX1 ARID4B NACA ZMYND8 SRF NSD1 ZMYM2 GON4L POU2F1 MAGEE2 DEPDC1 RUNX3 MEF2A TFDP2 HIRA PHC3 PER3 HEY1 GLI3 NFKB1 ZFHX3 MYOCD ELK3 MAGEC1 PRAME CNOT2 WWC1 | 4.00e-07 | 1413 | 160 | 30 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXO3 BCL9L SP1 HNF1A ARID4B NACA ZMYND8 SRF POU2F1 PHF8 RFX7 MEF2A TFDP2 MED19 HEY1 GLI3 NFKB1 NCOA1 ZFHX3 ELF4 MYOCD NR3C2 ELK3 MAML2 CAMTA1 HSF2 ZNF646 | 8.73e-06 | 1390 | 160 | 27 | GO:0045944 |
| GeneOntologyCellularComponent | chromatin | FOXO3 EPC2 SP1 HNF1A VAX1 ARID4B ACTR5 ZMYND8 SRF NSD1 GON4L POU2F1 RFX7 RUNX3 MEF2A TFDP2 HIRA MSL2 HEY1 NFKB1 NCOA1 ANKRD17 ZFHX3 ELF4 MYOCD NR3C2 ELK3 HSF2 PRAME | 3.22e-06 | 1480 | 162 | 29 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | FOXO3 BCL9L SP1 HNF1A POU2F1 DEPDC1 RUNX3 MEF2A TFDP2 MED19 GLI3 NFKB1 NCOA1 ZFHX3 MYOCD | 6.44e-05 | 596 | 162 | 15 | GO:0005667 |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 2.18e-04 | 110 | 162 | 6 | GO:0120111 | |
| Domain | - | 1.02e-04 | 218 | 158 | 9 | 1.10.10.10 | |
| Domain | TIG | 1.30e-04 | 31 | 158 | 4 | PF01833 | |
| Domain | IPT | 1.47e-04 | 32 | 158 | 4 | IPR002909 | |
| Domain | SEA | 2.02e-04 | 14 | 158 | 3 | SM00200 | |
| Domain | WHTH_DNA-bd_dom | 2.23e-04 | 242 | 158 | 9 | IPR011991 | |
| Domain | IMS | 4.22e-04 | 4 | 158 | 2 | PF00817 | |
| Domain | IMS_C | 4.22e-04 | 4 | 158 | 2 | PF11799 | |
| Domain | UMUC | 4.22e-04 | 4 | 158 | 2 | PS50173 | |
| Domain | G8_domain | 4.22e-04 | 4 | 158 | 2 | IPR019316 | |
| Domain | G8 | 4.22e-04 | 4 | 158 | 2 | PS51484 | |
| Domain | G8 | 4.22e-04 | 4 | 158 | 2 | SM01225 | |
| Domain | G8 | 4.22e-04 | 4 | 158 | 2 | PF10162 | |
| Domain | - | 4.22e-04 | 4 | 158 | 2 | 3.30.1490.100 | |
| Domain | DNA_pol_Y-fam_little_finger | 4.22e-04 | 4 | 158 | 2 | IPR017961 | |
| Domain | SEA | 9.29e-04 | 23 | 158 | 3 | PS50024 | |
| Domain | SEA_dom | 9.29e-04 | 23 | 158 | 3 | IPR000082 | |
| Domain | MADS_BOX_1 | 1.04e-03 | 6 | 158 | 2 | PS00350 | |
| Domain | PbH1 | 1.04e-03 | 6 | 158 | 2 | SM00710 | |
| Domain | MADS | 1.04e-03 | 6 | 158 | 2 | SM00432 | |
| Domain | SRF-TF | 1.04e-03 | 6 | 158 | 2 | PF00319 | |
| Domain | MADS_BOX_2 | 1.04e-03 | 6 | 158 | 2 | PS50066 | |
| Domain | PbH1 | 1.04e-03 | 6 | 158 | 2 | IPR006626 | |
| Domain | UmuC | 1.04e-03 | 6 | 158 | 2 | IPR001126 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.23e-07 | 16 | 113 | 5 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.73e-07 | 17 | 113 | 5 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 9.08e-07 | 23 | 113 | 5 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.74e-06 | 26 | 113 | 5 | M27483 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.11e-05 | 21 | 113 | 4 | MM15706 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.35e-05 | 25 | 113 | 4 | M27880 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 5.78e-05 | 10 | 113 | 3 | MM15535 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.36e-04 | 62 | 113 | 5 | M546 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.71e-04 | 14 | 113 | 3 | M27808 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.11e-04 | 68 | 113 | 5 | M27303 | |
| Pubmed | MKRN4P ZNF438 FOXO3 SP1 HNF1A MKRN1 ZMYND8 SRF ZMYM2 POU2F1 PHF8 ZNF236 RUNX3 PKHD1L1 MEF2A TFDP2 HIVEP3 ZCCHC14 PER3 HEY1 GLI3 NFKB1 PXN NCOA1 ZFHX3 CNOT2 ZNF646 | 1.75e-15 | 808 | 165 | 27 | 20412781 | |
| Pubmed | BCL9L EPC2 SP1 HNF1A UBAP2 ARID4B ACTR5 POLH NACA ZMYND8 ZMYM2 GON4L POU2F1 EDC4 PHF8 RFX7 MEF2A TFDP2 HIRA STAU1 PHC3 DST EIF4ENIF1 GSE1 GLI3 NFKB1 NCOA1 ANKRD17 ZFHX3 ELF4 ELK3 ZMYM1 LRIF1 CNOT2 | 5.96e-15 | 1429 | 165 | 34 | 35140242 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXO3 SP1 HNF1A VAX1 SRF GON4L POU2F1 RFX7 ZNF236 RUNX3 MEF2A TFDP2 HIVEP3 HEY1 GLI3 NFKB1 NCOA1 ZFHX3 ELF4 NR3C2 ELK3 CAMTA1 HSF2 | 6.87e-11 | 908 | 165 | 23 | 19274049 |
| Pubmed | MKRN4P SP1 HNF1A KIF1A MKRN1 ZMYND8 SRF POU2F1 MEF2A ZCCHC14 HEY1 GLI3 NFKB1 PXN NCOA1 ZFHX3 NR3C2 ELK3 CNOT2 | 1.41e-09 | 709 | 165 | 19 | 22988430 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXO3 RAPGEF6 SETD1B SPG7 MYO9B NSD1 RAPGEF1 EDC4 ZNF236 ARHGEF11 ZZEF1 HIRA HIVEP3 ZCCHC14 DST SLC2A4RG EIF4ENIF1 TULP4 NAV2 PXN HECTD1 HTT PCNT | 3.00e-09 | 1105 | 165 | 23 | 35748872 |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.84e-08 | 18 | 165 | 5 | 18834073 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | JCAD SP1 RAPGEF6 UBAP2 ZMYND8 PHC3 EIF4ENIF1 TULP4 ZMYM1 MAML2 CAMTA1 NEURL4 WNK4 PCNT | 2.10e-08 | 430 | 165 | 14 | 35044719 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 JCAD RAPGEF6 UBAP2 EDC4 LARP1B RFX7 ZCCHC14 USP31 FSIP2 DST FAM171A2 CCSER2 NAV2 ANKRD17 NR3C2 CRYBG3 HECTD1 WNK4 | 3.18e-08 | 861 | 165 | 19 | 36931259 |
| Pubmed | RAPGEF6 POLH ZMYND8 ZMYM2 PHC3 DST EIF4ENIF1 GSE1 PXN ANKRD17 ZFHX3 CRYBG3 PCNT | 1.16e-07 | 418 | 165 | 13 | 34709266 | |
| Pubmed | Upregulation of MUC6 mucin gene expression by NFkappaB and Sp factors. | 4.18e-07 | 4 | 165 | 3 | 15979574 | |
| Pubmed | WHRN SETD1B GON4L PHF8 SLC12A5 ZCCHC14 USP31 GSE1 SPHKAP DAAM2 CAMTA1 PCNT | 6.34e-07 | 407 | 165 | 12 | 12693553 | |
| Pubmed | BCL9L KIF1A ACTR5 MKRN1 NACA ZMYND8 NSD1 ZMYM2 GON4L EDC4 ARHGEF11 HIRA MSL2 PHC3 MED19 DST EIF4ENIF1 PXN ANKRD17 ULBP2 ZFHX3 EIF2AK2 CNOT2 | 7.12e-07 | 1497 | 165 | 23 | 31527615 | |
| Pubmed | RAPGEF6 KIAA0586 EDC4 LARP1B DST EIF4ENIF1 CRYBG3 HECTD1 WWC1 | 7.66e-07 | 209 | 165 | 9 | 36779422 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L EPC2 ARID4B ZMYM2 POU2F1 RFX7 HIRA GSE1 NCOA1 ZFHX3 LRIF1 | 1.04e-06 | 351 | 165 | 11 | 38297188 |
| Pubmed | 5.77e-06 | 8 | 165 | 3 | 7690421 | ||
| Pubmed | 5.77e-06 | 8 | 165 | 3 | 15522233 | ||
| Pubmed | EPC2 ARID4B ACTR5 ZMYND8 PHF8 ZZEF1 TFDP2 SLC5A11 EIF4ENIF1 GSE1 GLI3 RTL9 ANKRD17 DLG4 ZFHX3 CRYBG3 WWC1 ZNF646 | 6.57e-06 | 1116 | 165 | 18 | 31753913 | |
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 9738004 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | FOXO3 SP1 VAX1 SRF RFX7 RUNX3 HEY1 GLI3 ELF4 NR3C2 ELK3 HSF2 | 1.23e-05 | 544 | 165 | 12 | 28473536 |
| Pubmed | UBAP2 NHSL2 NSD1 ZMYM2 EDC4 ARHGEF11 HIRA SLC12A5 DST FAM171A2 SPHKAP ANKRD17 DLG4 WASF1 NEURL4 PCNT | 1.53e-05 | 963 | 165 | 16 | 28671696 | |
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 10847592 | ||
| Pubmed | FOXO3 EPC2 SP1 SETD1B ARID4B POU2F1 EDC4 ZNF236 PREX2 MSL2 CFAP92 GLI3 NCOA1 ANKRD17 MAML2 HECTD1 CNOT2 HTT PCNT | 1.91e-05 | 1327 | 165 | 19 | 32694731 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 8668525 | ||
| Pubmed | Bpag1 localization to actin filaments and to the nucleus is regulated by its N-terminus. | 2.24e-05 | 2 | 165 | 2 | 14576348 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 26203193 | ||
| Pubmed | Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins. | 2.24e-05 | 2 | 165 | 2 | 11242047 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 20599712 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15542842 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27612622 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16116232 | ||
| Pubmed | Genetic insights into fetal kidney development: Variants in HNF1A and PKHD1 genes. | 2.24e-05 | 2 | 165 | 2 | 38830515 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27545642 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 11319238 | ||
| Pubmed | Bidirectional control of postsynaptic density-95 (PSD-95) clustering by Huntingtin. | 2.24e-05 | 2 | 165 | 2 | 24347167 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 2108863 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16415359 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 37431882 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 22718346 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 36898841 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 19939936 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 32398139 | ||
| Pubmed | Sp1-dependent regulation of Myeloid Elf-1 like factor in human epithelial cells. | 2.24e-05 | 2 | 165 | 2 | 15907486 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 19726651 | ||
| Pubmed | Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase. | 2.24e-05 | 2 | 165 | 2 | 18772130 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 11468270 | ||
| Pubmed | Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. | 2.24e-05 | 2 | 165 | 2 | 15014501 | |
| Pubmed | Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma. | 2.24e-05 | 2 | 165 | 2 | 19604354 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16882727 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27106056 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 18512958 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 30143610 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 19943112 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23399035 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 19117014 | ||
| Pubmed | Serum response factor-cofactor interactions and their implications in disease. | 2.24e-05 | 2 | 165 | 2 | 32885587 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23544943 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 18083845 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 22399227 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 26918940 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 17037983 | ||
| Pubmed | O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. | 2.24e-05 | 2 | 165 | 2 | 19070619 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 35795985 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25938884 | ||
| Pubmed | Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB. | 2.24e-05 | 2 | 165 | 2 | 19141126 | |
| Pubmed | Translesion synthesis past estrogen-derived DNA adducts by human DNA polymerases eta and kappa. | 2.24e-05 | 2 | 165 | 2 | 15147214 | |
| Pubmed | An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene. | 2.24e-05 | 2 | 165 | 2 | 12721631 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21338484 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15003449 | ||
| Pubmed | SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer. | 2.24e-05 | 2 | 165 | 2 | 29565456 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 19414788 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 29046731 | ||
| Pubmed | Interaction of Huntington disease protein with transcriptional activator Sp1. | 2.24e-05 | 2 | 165 | 2 | 11839795 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 28649694 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.80e-05 | 123 | 165 | 6 | 26912792 | |
| Pubmed | 3.50e-05 | 128 | 165 | 6 | 30995482 | ||
| Pubmed | 4.53e-05 | 268 | 165 | 8 | 33640491 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | FNBP4 TFDP2 NFKB1 PXN ZFHX3 ELK3 CAMTA1 HECTD1 WASF1 CNOT2 WWC1 | 5.48e-05 | 536 | 165 | 11 | 15840001 |
| Pubmed | FNBP4 TFDP2 NFKB1 PXN ZFHX3 ELK3 CAMTA1 HECTD1 WASF1 CNOT2 WWC1 | 5.67e-05 | 538 | 165 | 11 | 10512203 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXO3 EPC2 ARID4B MYO9B ZMYND8 ZMYM2 POU2F1 DEPDC1 MEF2A HIRA GSE1 NFKB1 ANKRD17 WASF1 | 6.39e-05 | 857 | 165 | 14 | 25609649 |
| Pubmed | Abelson virus transformation prevents TRAIL expression by inhibiting FoxO3a and NF-kappaB. | 6.69e-05 | 3 | 165 | 2 | 20213318 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 23053434 | ||
| Pubmed | Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression. | 6.69e-05 | 3 | 165 | 2 | 23305535 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 31815603 | ||
| Pubmed | Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein. | 6.69e-05 | 3 | 165 | 2 | 10704334 | |
| Pubmed | Regulation of cardiac growth and development by SRF and its cofactors. | 6.69e-05 | 3 | 165 | 2 | 12858529 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 23112860 | ||
| Pubmed | STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin. | 6.69e-05 | 3 | 165 | 2 | 26100622 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 16151017 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 15728583 | ||
| Pubmed | Regulation of Egr-1, SRF, and Sp1 mRNA expression in contracting skeletal muscle cells. | 6.69e-05 | 3 | 165 | 2 | 15310743 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 11439182 | ||
| Pubmed | Regulation of NF-kappaB-dependent gene expression by the POU domain transcription factor Oct-1. | 6.69e-05 | 3 | 165 | 2 | 17192276 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 36610028 | ||
| Pubmed | TRIP/NOPO E3 ubiquitin ligase promotes ubiquitylation of DNA polymerase η. | 6.69e-05 | 3 | 165 | 2 | 24553286 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 24939955 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 28765909 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 9786846 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 17215356 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 33743134 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 24204843 | ||
| Interaction | NUP43 interactions | BCL9L SETD1B ARID4B ACTR5 POLH ZMYND8 NSD1 ZMYM2 GON4L CCDC168 PHF8 MSL2 FSIP2 PHC3 DST EIF4ENIF1 GSE1 CCSER2 ZFHX3 ELF4 ZMYM1 HSF2 | 3.94e-09 | 625 | 158 | 22 | int:NUP43 |
| Interaction | YWHAH interactions | FOXO3 JCAD TICRR RAPGEF6 UBAP2 NHSL2 EDC4 LARP1B RFX7 ZCCHC14 USP31 DST FAM171A2 CCSER2 NAV2 NCOA1 ANKRD17 NR3C2 CRYBG3 HECTD1 WASF1 WWC1 HTT PCNT | 5.26e-06 | 1102 | 158 | 24 | int:YWHAH |
| Interaction | GSK3A interactions | RAPGEF6 KIAA0586 EDC4 LARP1B RFX7 ARHGEF11 DST EIF4ENIF1 GLI3 PXN CRYBG3 HECTD1 MTCH1 WWC1 | 1.81e-05 | 464 | 158 | 14 | int:GSK3A |
| Interaction | TOP3B interactions | FOXO3 RAPGEF6 UBAP2 SETD1B SPG7 MYO9B NSD1 RAPGEF1 EDC4 ZNF236 ARHGEF11 ZZEF1 HIRA STAU1 HIVEP3 ZCCHC14 DST SLC2A4RG EIF4ENIF1 TULP4 NAV2 PXN ANKRD17 HECTD1 CNOT2 HTT PCNT | 2.82e-05 | 1470 | 158 | 27 | int:TOP3B |
| Interaction | POGZ interactions | 4.73e-05 | 265 | 158 | 10 | int:POGZ | |
| Interaction | HDAC1 interactions | SP1 RAPGEF6 ARID4B POLH ZMYND8 ZMYM2 GON4L POU2F1 RUNX3 MEF2A STAU1 DST EIF4ENIF1 GSE1 GLI3 NFKB1 PXN ANKRD17 ZFHX3 CRYBG3 HECTD1 PCNT | 5.50e-05 | 1108 | 158 | 22 | int:HDAC1 |
| Interaction | RXRA interactions | 5.74e-05 | 169 | 158 | 8 | int:RXRA | |
| Interaction | YY1 interactions | SP1 ARID4B ACTR5 ZMYND8 ZMYM2 GON4L MSL2 PHC3 NFKB1 ELF4 ELK3 ZMYM1 LRIF1 | 6.21e-05 | 454 | 158 | 13 | int:YY1 |
| Interaction | PCGF6 interactions | 6.23e-05 | 171 | 158 | 8 | int:PCGF6 | |
| GeneFamily | CD molecules|Mucins | 1.31e-07 | 21 | 108 | 5 | 648 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 3.49e-04 | 5 | 108 | 2 | 1086 | |
| GeneFamily | Zinc fingers MYM-type | 5.22e-04 | 6 | 108 | 2 | 86 | |
| GeneFamily | PDZ domain containing | 2.19e-03 | 152 | 108 | 5 | 1220 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FOXO3 MYO9B ZMYND8 MAMLD1 ZMYM2 PHF8 ZZEF1 MBOAT2 MEF2A HIRA DST ZFYVE9 GSE1 NFKB1 CCSER2 NCOA1 ANKRD17 ZFHX3 CRYBG3 WASF1 CNOT2 WWC1 PCNT | 3.78e-09 | 856 | 163 | 23 | M4500 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | FOXO3 ARID4B MKRN1 FNBP4 GON4L POU2F1 MEF2A TFDP2 ZCCHC14 DST PER3 GSE1 HEY1 CCSER2 CCNA1 NAV2 NCOA1 HSF2 LRIF1 | 9.42e-07 | 822 | 163 | 19 | M6782 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | MKRN4P JCAD COL6A3 SGCB MKRN1 KIAA0586 ZMYND8 RAPGEF1 CUBN TMEM80 MBOAT2 HIRA NEO1 DST PER3 TULP4 HEY1 NAV2 ZFHX3 WASF1 HTT | 6.99e-06 | 1124 | 163 | 21 | MM1070 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | JCAD COL6A3 SGCB MKRN1 KIAA0586 ZMYND8 RAPGEF1 CUBN TMEM80 MBOAT2 HIRA NEO1 DST PER3 TULP4 HEY1 NAV2 ZFHX3 WASF1 HTT | 1.79e-05 | 1102 | 163 | 20 | M2369 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 3.65e-05 | 199 | 163 | 8 | M5893 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | FOXO3 ZMYND8 MAMLD1 ZMYM2 HIRA DST ZFYVE9 CCSER2 NCOA1 ANKRD17 CNOT2 WWC1 | 3.73e-05 | 466 | 163 | 12 | M13522 |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 3.78e-05 | 200 | 163 | 8 | M7500 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 3.78e-05 | 200 | 163 | 8 | M6102 | |
| Coexpression | MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP | 3.93e-05 | 61 | 163 | 5 | M1559 | |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | MAMLD1 ZCCHC14 DST SH3GLB1 TULP4 NCOA1 ANKRD17 HSF2 NNT PCNT | 5.64e-05 | 340 | 163 | 10 | M2012 |
| Coexpression | GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP | 6.39e-05 | 159 | 163 | 7 | M6502 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | GABRE NHSL2 PREX2 ZCCHC14 DST SH3GLB1 PER3 NAV2 MYOCD NR3C2 MUC4 NNT | 6.41e-05 | 493 | 163 | 12 | M19391 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | GABRE EPC2 TICRR VAX1 ARID4B MAMLD1 ZMYM2 POU2F1 SHC3 PREX2 STAU1 MSL2 COG1 GLI3 ZFHX3 ZMYM1 MUC4 MUC6 NEURL4 LMNTD1 LRIF1 | 1.33e-05 | 989 | 157 | 21 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-06 | 163 | 165 | 7 | 7864e966c228282b4b63c43164dba3faba21026d | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 6.17e-06 | 186 | 165 | 7 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.86e-06 | 189 | 165 | 7 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.86e-06 | 189 | 165 | 7 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.26e-06 | 125 | 165 | 6 | 6cd741dd1c7ee6b16437cca7c15c99b5c95603fc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 191 | 165 | 7 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 191 | 165 | 7 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.86e-06 | 193 | 165 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-06 | 194 | 165 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 197 | 165 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 197 | 165 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 197 | 165 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.28e-06 | 198 | 165 | 7 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.28e-06 | 198 | 165 | 7 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.28e-06 | 198 | 165 | 7 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 9.59e-06 | 199 | 165 | 7 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 155 | 165 | 6 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.66e-05 | 157 | 165 | 6 | f2bc60ec0305b056d79f1b7fd6b5e3730d606916 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-05 | 169 | 165 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.15e-05 | 170 | 165 | 6 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 172 | 165 | 6 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 172 | 165 | 6 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-05 | 175 | 165 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-05 | 177 | 165 | 6 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 178 | 165 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-05 | 181 | 165 | 6 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 5.88e-05 | 181 | 165 | 6 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-05 | 181 | 165 | 6 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.88e-05 | 181 | 165 | 6 | 0ba91575fe8851788cebc4cf5a6d76680bf586c5 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.06e-05 | 182 | 165 | 6 | 345d0f9d5ee30434bc2aac17608ccdc9e61c8fa3 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.24e-05 | 183 | 165 | 6 | 450c30d2e389fcb17825394c27f9ccc4f33022e3 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.44e-05 | 184 | 165 | 6 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 186 | 165 | 6 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 187 | 165 | 6 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 187 | 165 | 6 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 188 | 165 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 7.46e-05 | 189 | 165 | 6 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.46e-05 | 189 | 165 | 6 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.68e-05 | 190 | 165 | 6 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-05 | 190 | 165 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-05 | 190 | 165 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.68e-05 | 190 | 165 | 6 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-05 | 191 | 165 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-05 | 191 | 165 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 7.91e-05 | 191 | 165 | 6 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-05 | 191 | 165 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.91e-05 | 191 | 165 | 6 | 04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.91e-05 | 191 | 165 | 6 | db8dd6bbba803585bdd6a55d5c403d383f2e9acf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.91e-05 | 191 | 165 | 6 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 192 | 165 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 192 | 165 | 6 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 192 | 165 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.37e-05 | 193 | 165 | 6 | 3a9fe4e709c09ec787c71bdd6b58a71c419896de | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.37e-05 | 193 | 165 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-05 | 194 | 165 | 6 | cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.62e-05 | 194 | 165 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.62e-05 | 194 | 165 | 6 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-05 | 194 | 165 | 6 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-05 | 195 | 165 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 8.86e-05 | 195 | 165 | 6 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-05 | 195 | 165 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 9.11e-05 | 196 | 165 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.11e-05 | 196 | 165 | 6 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 9.11e-05 | 196 | 165 | 6 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.11e-05 | 196 | 165 | 6 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.11e-05 | 196 | 165 | 6 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.11e-05 | 196 | 165 | 6 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-05 | 197 | 165 | 6 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.37e-05 | 197 | 165 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-05 | 197 | 165 | 6 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | 5'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.64e-05 | 198 | 165 | 6 | 90e85fe7a0ab376a41666dfff6c0e95b7f1c9475 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 198 | 165 | 6 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.91e-05 | 199 | 165 | 6 | b15304d3d3f6c254969b54a61bee3d9f368840b2 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.91e-05 | 199 | 165 | 6 | ffebd99d55d31cf51b4878b2690ed0b9b3799223 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.91e-05 | 199 | 165 | 6 | 258d59cf811bf1668ffbb5f18f961021f660de62 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 165 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Vein|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 165 | 6 | b3f93b71589251197cde96b7bc6d065c106f61cd | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 165 | 6 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 165 | 6 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 165 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 165 | 6 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 200 | 165 | 6 | 2554b77edfe3d378296b0b25625caacbfb1c0e76 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 165 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 165 | 6 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.02e-04 | 200 | 165 | 6 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 126 | 165 | 5 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.18e-04 | 68 | 165 | 4 | ad6c363d7fb3c436e894db30a544748c5df75a45 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.18e-04 | 68 | 165 | 4 | 82d928f5eefa065d26096a84b0d78f131dcc8c73 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.18e-04 | 68 | 165 | 4 | d97199a8c6afa79bff1600f00c2dbf6286df24a2 | |
| Computational | Genes in the cancer module 123. | HNF1A POU2F1 RUNX3 MEF2A NFKB1 ZFHX3 ELF4 HSF2 EIF2AK2 ZNF646 | 5.19e-05 | 247 | 93 | 10 | MODULE_123 |
| Computational | Neighborhood of ZNF198 | 6.61e-05 | 117 | 93 | 7 | GCM_ZNF198 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | ARID4B KIAA0586 ZMYM2 POU2F1 GLI3 CCSER2 NAV2 NCOA1 ANKRD17 WWC1 | 4.76e-07 | 171 | 164 | 10 | 7535_DN |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.02e-07 | 172 | 164 | 10 | 7073_DN | |
| Drug | staurosporine; Down 200; 0.01uM; MCF7; HG-U133A | 1.30e-05 | 196 | 164 | 9 | 425_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; HL60; HG-U133A | 1.41e-05 | 198 | 164 | 9 | 1423_UP | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 1.41e-05 | 198 | 164 | 9 | 5298_DN | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.24e-06 | 64 | 158 | 6 | DOID:4947 (is_marker_for) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.49e-06 | 5 | 158 | 3 | DOID:3030 (is_marker_for) | |
| Disease | level of UL16-binding protein 6 in blood serum | 2.85e-05 | 2 | 158 | 2 | OBA_2043185 | |
| Disease | severe acute respiratory syndrome, COVID-19 | COL6A3 MAMLD1 PREX2 PXN ULBP2 ZFHX3 RAET1L MAML2 CAMTA1 NMBR EIF2AK2 | 3.12e-05 | 447 | 158 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | thalamus volume | 9.60e-05 | 85 | 158 | 5 | EFO_0006935 | |
| Disease | vital capacity | ZNF438 FOXO3 COL6A3 KIF1A HLA-DRB1 POM121L2 ZZEF1 STAU1 DST SLC2A4RG TULP4 GLI3 RTL9 NCOA1 ZFHX3 ELF4 NMBR NNT | 1.17e-04 | 1236 | 158 | 18 | EFO_0004312 |
| Disease | fibrinogen measurement, coronary artery disease | 1.87e-04 | 154 | 158 | 6 | EFO_0001645, EFO_0004623 | |
| Disease | neutrophil count, basophil count | 2.14e-04 | 224 | 158 | 7 | EFO_0004833, EFO_0005090 | |
| Disease | wellbeing measurement | FAT4 RAPGEF6 HLA-DRB1 ZMYND8 FNBP4 POM121L2 SLC12A5 STAU1 ZCCHC14 PKHD1 ZFHX3 NR3C2 | 3.69e-04 | 692 | 158 | 12 | EFO_0007869 |
| Disease | venous thromboembolism, fibrinogen measurement | 4.67e-04 | 67 | 158 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | longevity, healthspan, parental longevity | 4.97e-04 | 29 | 158 | 3 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | Myeloid Leukemia, Chronic | 4.97e-04 | 29 | 158 | 3 | C0023473 | |
| Disease | testosterone measurement | ZNF438 DCHS2 HNF1A NHSL2 MYO9B HLA-DRB1 FNBP4 MFSD9 MSL2 SLC2A4RG PER3 NFKB1 RTL9 NCOA1 DAAM2 ZFHX3 MYOCD | 5.06e-04 | 1275 | 158 | 17 | EFO_0004908 |
| Disease | Nonorganic psychosis | 5.22e-04 | 69 | 158 | 4 | C0349204 | |
| Disease | level of Sphingomyelin (d36:2) in blood serum | 5.88e-04 | 7 | 158 | 2 | OBA_2045177 | |
| Disease | pseudohypoaldosteronism (is_implicated_in) | 7.81e-04 | 8 | 158 | 2 | DOID:4479 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 8.04e-04 | 364 | 158 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Moderate albuminuria | 9.12e-04 | 80 | 158 | 4 | HP_0012594 | |
| Disease | FEV/FEC ratio | ZNF438 FOXO3 JCAD COL6A3 DCHS2 CES5A KIAA0586 NSD1 RUNX3 HIVEP3 DST CCSER2 NAV2 ZFHX3 MAML2 NMBR | 9.46e-04 | 1228 | 158 | 16 | EFO_0004713 |
| Disease | Schizophrenia | SP1 RAPGEF6 EFCAB11 MYO9B HLA-DRB1 ESAM ARHGEF11 SLC1A6 SLC12A5 DAAM2 DLG4 MAGEC1 PCNT | 9.73e-04 | 883 | 158 | 13 | C0036341 |
| Disease | dentate gyrus volume measurement | 1.20e-03 | 39 | 158 | 3 | EFO_0010083 | |
| Disease | hypospadias | 1.20e-03 | 39 | 158 | 3 | EFO_0004209 | |
| Disease | celiac disease (is_implicated_in) | 1.25e-03 | 10 | 158 | 2 | DOID:10608 (is_implicated_in) | |
| Disease | Pseudohypoaldosteronism, Type I | 1.25e-03 | 10 | 158 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 1.25e-03 | 10 | 158 | 2 | C0033805 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 1.25e-03 | 10 | 158 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 1.25e-03 | 10 | 158 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 1.25e-03 | 10 | 158 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 1.25e-03 | 10 | 158 | 2 | C1449842 | |
| Disease | body fat percentage | 1.32e-03 | 488 | 158 | 9 | EFO_0007800 | |
| Disease | hippocampal CA4 volume | 1.38e-03 | 41 | 158 | 3 | EFO_0009396 | |
| Disease | serum albumin measurement | HNF1A HLA-DRB1 MAMLD1 LARP1B ZZEF1 MSL2 RTL9 DLG4 SERPINA9 PCNT | 1.38e-03 | 592 | 158 | 10 | EFO_0004535 |
| Disease | nucleus accumbens volume change measurement | 1.52e-03 | 11 | 158 | 2 | EFO_0021493 | |
| Disease | interleukin-22 receptor subunit alpha-2 measurement | 1.52e-03 | 11 | 158 | 2 | EFO_0020500 | |
| Disease | Paroxysmal atrial fibrillation | 1.56e-03 | 156 | 158 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.56e-03 | 156 | 158 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.56e-03 | 156 | 158 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 1.74e-03 | 160 | 158 | 5 | C0004238 | |
| Disease | Malignant neoplasm of breast | ZNF438 GABRP POLH MFSD9 POU2F1 CUBN GRM6 ZCCHC14 PER3 HEY1 NCOA1 ELK3 NMBR ZNF646 | 1.97e-03 | 1074 | 158 | 14 | C0006142 |
| Disease | alpha fetoprotein measurement | 2.08e-03 | 100 | 158 | 4 | EFO_0010583 | |
| Disease | Psychotic Disorders | 2.16e-03 | 101 | 158 | 4 | C0033975 | |
| Disease | cortical surface area measurement | ZNF438 FOXO3 SP1 TICRR DCHS2 MYO9B TFDP2 NEO1 GLI3 NFKB1 PKHD1 NAV2 ZFHX3 NR3C2 ELK3 WWC1 | 2.39e-03 | 1345 | 158 | 16 | EFO_0010736 |
| Disease | sulfate measurement | 2.49e-03 | 14 | 158 | 2 | EFO_0007864 | |
| Disease | blood phosphate measurement | 2.51e-03 | 174 | 158 | 5 | EFO_0010972 | |
| Disease | platelet component distribution width | FOXO3 JCAD MYO9B ZMYND8 MAMLD1 CUBN ZZEF1 GSE1 NR3C2 CAMTA1 POLK | 2.58e-03 | 755 | 158 | 11 | EFO_0007984 |
| Disease | fibrinogen measurement | 2.85e-03 | 109 | 158 | 4 | EFO_0004623 | |
| Disease | prostate carcinoma | COL6A3 UBAP2 MYO9B NSD1 RFX7 ZNF236 PHC3 SLC2A4RG PKHD1 ZFHX3 MYOCD LRIF1 | 3.16e-03 | 891 | 158 | 12 | EFO_0001663 |
| Disease | Ischemic stroke, fibrinogen measurement | 3.22e-03 | 55 | 158 | 3 | EFO_0004623, HP_0002140 | |
| Disease | free cholesterol measurement | 3.24e-03 | 113 | 158 | 4 | EFO_0008591 | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 3.25e-03 | 16 | 158 | 2 | OBA_2045195 | |
| Disease | lymphocyte measurement | 3.67e-03 | 117 | 158 | 4 | EFO_0803546 | |
| Disease | prostate cancer (is_implicated_in) | 3.67e-03 | 117 | 158 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | response to radiation, Urinary retention | 3.68e-03 | 17 | 158 | 2 | GO_0009314, HP_0000016 | |
| Disease | muscular dystrophy (is_implicated_in) | 3.68e-03 | 17 | 158 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Moyamoya Disease | 3.68e-03 | 17 | 158 | 2 | C0026654 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.68e-03 | 17 | 158 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | fibrinogen measurement, factor VII measurement | 3.75e-03 | 58 | 158 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | immature platelet measurement | 3.90e-03 | 119 | 158 | 4 | EFO_0803541 | |
| Disease | glycoprotein measurement | 3.90e-03 | 119 | 158 | 4 | EFO_0004555 | |
| Disease | reticulocyte count | FOXO3 SP1 UBAP2 MYO9B HLA-DRB1 HMGCL RUNX3 FAM83C SLC12A5 MED19 SERPINB9 NFKB1 EIF2AK2 | 4.20e-03 | 1045 | 158 | 13 | EFO_0007986 |
| Disease | cleft lip | 4.38e-03 | 284 | 158 | 6 | EFO_0003959 | |
| Disease | level of Sphingomyelin (d38:2) in blood serum | 4.59e-03 | 19 | 158 | 2 | OBA_2045179 | |
| Disease | myeloid white cell count | JCAD HNF1A SETD1B HLA-DRB1 PREX2 HIVEP3 SPPL2A CSF3R NFKB1 ZFHX3 HSF2 HTT | 4.70e-03 | 937 | 158 | 12 | EFO_0007988 |
| Disease | arterial stiffness measurement | 4.94e-03 | 64 | 158 | 3 | EFO_0004517 | |
| Disease | monocyte count | JCAD ARID4B GON4L SHC3 PREX2 TFDP2 HIVEP3 SERPINB9 SPPL2A GSE1 CSF3R NFKB1 CFAP45 NCOA1 LMNTD1 | 4.97e-03 | 1320 | 158 | 15 | EFO_0005091 |
| Disease | neuroimaging measurement | ZNF438 FOXO3 SP1 DCHS2 UBAP2 ARHGEF11 NEO1 GLI3 PKHD1 NAV2 CAMTA1 WWC1 HTT | 5.07e-03 | 1069 | 158 | 13 | EFO_0004346 |
| Disease | myelodysplastic syndrome (is_marker_for) | 5.08e-03 | 20 | 158 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | susceptibility to vaginal yeast infection measurement | 5.16e-03 | 65 | 158 | 3 | EFO_0008412 | |
| Disease | lobe attachment | 5.24e-03 | 207 | 158 | 5 | EFO_0007667 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSSSSITAAVMLTLA | 1281 | Q4LE39 | |
| TSLMDILPTVASVSG | 401 | P54793 | |
| TNMALSSSPGISAVQ | 681 | Q52LR7 | |
| TTGSSESLSMLPTNV | 446 | Q9Y6Y1 | |
| TSLGMDTSLGLQSPS | 286 | A6NCI8 | |
| PLLLSASTDSSMKGN | 281 | Q68DQ2 | |
| MSTSLGKTALPSQAL | 1356 | Q8IZF6 | |
| DSLLNIMTTTSTVPG | 2176 | Q8IZF6 | |
| SSPGLSARATVSIMI | 326 | P31997 | |
| PSLGMLSTATRTTAT | 11 | Q14687 | |
| VLMITATDSGSPALT | 2331 | Q6V0I7 | |
| ALTLLGSSPSSMGIS | 116 | O15085 | |
| MQLPFSSKLLGSTLT | 276 | Q9H9F9 | |
| SVSRTPTISLAGASM | 301 | Q9ULG3 | |
| SAPTTTAANTSLMGI | 1821 | O75179 | |
| SATLAMSTINLPSTL | 176 | P00846 | |
| PSGLTRSTSMLISSG | 566 | Q9Y485 | |
| LSRASGGSSPQSSMI | 241 | Q8IWA6 | |
| SSSLSSIVGPLVEMN | 166 | Q13434 | |
| TSTLGNMLELPGTSS | 286 | Q96L73 | |
| NMLELPGTSSSSTSQ | 291 | Q96L73 | |
| SPKLQLDGSLTMSSS | 656 | Q6P2E9 | |
| TMSSSGSLQASPRGL | 666 | Q6P2E9 | |
| GGPLTLSSSMTTNDL | 526 | Q86T65 | |
| TQSLGVMSSALPEST | 76 | Q8WXI7 | |
| ATSQVTLPLGTSMTF | 9671 | Q8WXI7 | |
| LPVTSLSSASTGDTM | 1521 | Q99102 | |
| MTLTTSGTSQALSSL | 1671 | Q6W4X9 | |
| PTSMTLTTSLPNLLS | 216 | C9J442 | |
| MPSKSLSNLSVTTGA | 1 | P28336 | |
| SSLMSGALSPSIIQN | 1516 | P10071 | |
| NVGSPLSSPLSSMKS | 256 | P08235 | |
| SLLQIPMTSSFSSTL | 336 | O60732 | |
| PMTSSFSSTLLSILQ | 411 | O60732 | |
| IQATNASGSPTSMLV | 26 | Q8TD90 | |
| SSGNLIPLVQSSVMS | 51 | Q5T3J3 | |
| MATTSTTGSTLLQPL | 1 | Q6ZWT7 | |
| APTMGAVVLSSTLLS | 371 | Q8NBP5 | |
| LRSLSGTPKSMTSLS | 521 | Q8IX03 | |
| SGSLLMAEPSVTTSG | 621 | Q99607 | |
| MAEPSVTTSGSLLTR | 626 | Q99607 | |
| GLTQSLTPSLTSSSM | 521 | Q03001 | |
| LTPSLTSSSMTSGLS | 526 | Q03001 | |
| SLSTGMQVPSAVRTL | 496 | Q9BXM9 | |
| RLSISAESQSPGTSM | 1016 | P46020 | |
| SPALQEQSLLSMSST | 616 | Q9P266 | |
| MTQSPSLLSASTGDR | 26 | A0A087WSZ0 | |
| MSDLTQAIPSLSSVT | 716 | Q5CZC0 | |
| MPLSTAGILSSSSAA | 1 | Q9UL16 | |
| GAPQILSTAMLSLGS | 611 | P56645 | |
| TMTRPTTAGLLLSSQ | 106 | Q9UBM4 | |
| LAVSDMGLSLSSLPT | 66 | Q8NH64 | |
| NMTGTLSTVTSLRPT | 1861 | Q02505 | |
| SAGAISVSSLILSPM | 226 | Q6NT32 | |
| LSENSLLPASSMLTG | 571 | Q5TB30 | |
| VPVINSMGSSLTTLQ | 446 | P20823 | |
| SMGSSLTTLQPVQFS | 451 | P20823 | |
| MLGSVATTLPLSSSN | 26 | Q8N9Z9 | |
| SLGITSVLTMTTLGT | 311 | P78334 | |
| PSLAASSTLTDSSML | 166 | Q02078 | |
| QASLSPMSESTLSIA | 171 | Q9HCI7 | |
| PMSESTLSIAIGSSV | 176 | Q9HCI7 | |
| MSGTGTTSSAPLALL | 166 | Q969R2 | |
| QDMSLSSPTSVLGGS | 2186 | O95613 | |
| SITQQTMLLGSTSPT | 151 | Q8NDX5 | |
| TMLLGSTSPTLTASQ | 156 | Q8NDX5 | |
| SLMSSLNGGSVPSEL | 496 | Q8IZQ8 | |
| TLSGALSPALMSNST | 621 | P14859 | |
| TIDPMSGTLKTSNTL | 1981 | Q6V1P9 | |
| AAMASPTAGLVTITS | 291 | A8MVW0 | |
| PTVMSTSLGSNLSEL | 131 | P49023 | |
| SSLLSTSHGTRMPSL | 846 | Q8IZL2 | |
| SLLKSSRSPFSGTMT | 321 | Q9H7U1 | |
| PSLTSSGNSLMLVFV | 1011 | O60494 | |
| LSVSSLLAAGAPMSS | 1516 | Q9ULT8 | |
| NTLGRNVMSTATSPL | 1576 | Q9ULT8 | |
| HSLSSTKLLSPQMSG | 1861 | P42858 | |
| TVSLSLSASVSLGML | 821 | O15303 | |
| SSQIRFGLLPLSMTS | 906 | Q8WTW3 | |
| LLTTTNSSEGLSMGN | 86 | P19525 | |
| TSLSSIKQSPLMGRS | 346 | Q9BQN1 | |
| TVSPMLVDSSLLSQS | 181 | P78396 | |
| SSSTINLMVSTEPLA | 3091 | P12111 | |
| TSLSSGMLTQNTNVP | 76 | Q3T8J9 | |
| NSSTTLSNMEQGTLP | 1031 | Q86UU0 | |
| TVTLMVLSSPLALSG | 16 | P01911 | |
| LITAMGTSSSSATLP | 381 | P48664 | |
| AGATNSTVLTLMTLT | 606 | Q99062 | |
| LMNSSLGSGTASLRS | 411 | P78352 | |
| KISSLMLPNAASISS | 221 | P41970 | |
| RGSLSLTNLSSSMAG | 206 | Q96AP7 | |
| VTGMSLQIPSSSTGI | 246 | Q13495 | |
| RGSPNALLSSMTSSS | 381 | Q13495 | |
| FGPQSSILANLMSST | 421 | Q13495 | |
| GSLNGTTMTLPATTL | 46 | P01854 | |
| TTMTLPATTLTLSGH | 51 | P01854 | |
| MAPTGLSSLTVNSTA | 51 | Q9BZJ6 | |
| LGSMSPTTSSQILAR | 36 | Q9Y5J3 | |
| NGTSAVTSASEMLLP | 6521 | Q8NDH2 | |
| SIPLSGSLAGTMLSS | 481 | P54198 | |
| DSVMSSINPNTSGIL | 61 | Q9BUY7 | |
| QSSPLVTSSGSMSTL | 891 | Q9ULU4 | |
| SMSTLVSSVNADLPI | 901 | Q9ULU4 | |
| SNTLKISGMTAQLPS | 871 | B7ZC32 | |
| ITNATGPMDNSLATS | 881 | Q96JN8 | |
| TTLMIGSRTSLPNTN | 286 | O00591 | |
| NALVGMSPSSSLSAL | 396 | Q12756 | |
| SILQAMSRGLSTSLP | 351 | Q659C4 | |
| PSSASRGMLSAITNV | 201 | Q8IWE2 | |
| DTSPMVSSLLSGLAN | 76 | Q9H2X9 | |
| SDGSSPLMSSAVQLN | 316 | Q03933 | |
| PLMSSAVQLNGSSSL | 321 | Q03933 | |
| ILSSSFNPITGTMLA | 136 | A0JLT2 | |
| SSSLSSIVGPLVEMN | 131 | Q9UHC7 | |
| TSMLTSTLSEGSTPL | 381 | Q685J3 | |
| PSEGSSSLTTMLLSS | 3571 | Q685J3 | |
| PLMSVTNAISGLTAV | 526 | Q13423 | |
| NASTVSGRLSPIMAS | 316 | O43524 | |
| GLSPRLMSNALSTVT | 151 | Q9NZJ7 | |
| GTSISSLSVAGMPAT | 286 | Q13761 | |
| PSLLTRASSSGEMSL | 781 | Q8NET4 | |
| GLMSTLSQPVSRASS | 1101 | Q2M3C7 | |
| SSSSPDLLQPTTSML | 726 | Q8TEU7 | |
| PSVSQLSVLSLSGVM | 346 | P78395 | |
| RGSSTVLSSVPLQML | 81 | Q96HE8 | |
| SFSGQVSSSSLMPLT | 676 | Q8N3X1 | |
| TSSPNLDLSGMSISI | 776 | Q5HYW2 | |
| NISTLSSPVGMTSSA | 511 | Q15788 | |
| ASLRAVSTSSMGTLP | 16 | P35914 | |
| PIGTSMSLSDRANST | 1286 | Q92859 | |
| QVSISASPRQSMGLS | 1971 | Q8IVL1 | |
| AGMSISLTISTASLN | 221 | Q92529 | |
| SSAMASTSGLVITSP | 281 | Q9Y371 | |
| LNISTSVQLAASMPS | 276 | Q9UHJ6 | |
| SLTLSQNGMPEASSS | 576 | Q8WWX8 | |
| LQMEGSPISSSSSQL | 526 | Q9UPS6 | |
| MPLTSTSLTIGSLAL | 366 | P03915 | |
| GVSVLISSISPMLNS | 271 | A6NDL8 | |
| MNAPLDGLSVSSSST | 1 | Q9P202 | |
| PVMDALSTNTSGSLT | 1486 | P08F94 | |
| ASLSSLTAPTQAPMS | 496 | Q9Y253 | |
| ILNGSVMVSTTRLPS | 256 | Q16585 | |
| VMSLLNALSTSGGSI | 151 | Q9UQ90 | |
| GTATPSALITTNMVA | 736 | P08047 | |
| STLLGMVSSPTSHLS | 506 | Q96KW2 | |
| QMIISTPQRLTSSGS | 61 | Q14188 | |
| SPVSVSTSLAMLSLG | 71 | Q86WD7 | |
| VSSGGLMQLPTSFTL | 331 | P11831 | |
| SNLLSGLMGSLEPTT | 541 | Q9NRA8 | |
| IPSRTNSMSSSGLGS | 151 | Q9NZN8 | |
| SSAQAMSPTQSIGLV | 696 | Q9NRJ4 | |
| LSEPLNTSLSMTSAV | 571 | Q5T6F2 | |
| TGVISPLSASAMILT | 406 | Q7Z2Z1 | |
| SPVSISSALAMVLLG | 31 | P50453 | |
| SLLSQPLMSIPSTTS | 26 | O95793 | |
| MSRATSGSSLPVGIN | 306 | Q13905 | |
| MAAAALTSLSTSPLL | 106 | Q9NR83 | |
| ALPSTLENATSISLM | 51 | Q8TCT8 | |
| TLTASAGIAPNTMLA | 306 | Q9UBT6 | |
| GQRTAMLTATSTQPL | 426 | Q5T1R4 | |
| PSAQMLNGSAELSTS | 346 | O15015 | |
| TITTMAAPSGLSLGQ | 991 | Q70Z35 | |
| APLAMSSGTTQLRAT | 211 | Q5VY80 | |
| TPTSEMIAGSQSLSR | 866 | Q2KHR2 | |
| TSLPTKSLNMGISLT | 11 | M5A8F1 | |
| SILGFNISSMSITNP | 4036 | Q86WI1 | |
| PVLLGSTAMATSLTN | 16 | Q9UBW7 | |
| PVQVLSGLSESSSMS | 571 | Q8WYQ9 | |
| SLLTSLVTASMETNP | 401 | O43149 | |
| SLLQAPSSDGMNVTT | 921 | Q9UL36 | |
| PSAISTQNLVMSSSG | 1546 | Q9UL36 | |
| TSVSMSRLSLPSKNG | 511 | Q9UPP1 | |
| LSGAMASISVRSSTP | 196 | Q14CZ0 | |
| SLSALPFSQMSELLT | 251 | Q92558 | |
| LSLASSGVNKMLPSV | 66 | Q5SVZ6 | |
| MASLRSPSTSIKSGL | 1201 | Q70CQ4 | |
| APLAMSSGTTQLRAT | 211 | Q9BZM5 | |
| IELMSPASSNSSGSL | 726 | Q59H18 | |
| TLASLASPTTLQSQM | 446 | Q7Z4V0 | |
| SLAVMTVAQSLLSPS | 931 | Q96J92 | |
| SIGRDPSMSAITSLT | 251 | O95405 | |
| SQMPGSDSSTLESTL | 1201 | Q9BVV6 | |
| MPNVLQTLSRGTAST | 536 | Q15911 | |
| SSNLLSQVPTESVGM | 1676 | Q15911 | |
| LGSVASRLSSAPLTM | 281 | Q5SQQ9 | |
| SRLSSAPLTMAGSLA | 286 | Q5SQQ9 | |
| LPMSSALSVTAALGQ | 26 | E9PAV3 | |
| AASPSAMLSQSLDLS | 1321 | Q13459 | |
| SLTSGASLLTLNKMP | 941 | P19838 |